The color of longer IBR protection.
BOVILIS® NASALGEN® 3 offers young calves an unrivaled BRD defense. With 6.5 months of IBR protection plus BRSV and PI3, BOVILIS NASALGEN 3 is the insurance you need to give your young calves the strong foundation they deserve. And with a unique blue shadow, there’s no second guessing which animals have been vaccinated.
Designed for no injection site reactions to help your operation meet Beef Quality Assurance standards.
Key Benefits
- Designed with an IBR that is not temperature-sensitive, ensuring the vaccine will replicate and protect in any situation.1
- Unique blue shadow for confident administration.
- Proven safe in pregnant cows and in calves nursing pregnant cows.
Long-lasting Duration of Immunity
- Six and a half months against IBR
- Three months against PI3
- 11 weeks against BRSV
Dosing and Usage
- Convenient, single 2 mL dose in one nostril
- Mimics natural exposure to the most common causes of pneumonia for an effective immune response
- SUPPLIED: 1-dose, 10-dose, 50-dose
Research
Duration of Immunity of the Parainfluenza 3 Fraction
Results of this study demonstrate the duration of immunity of the PI3 fraction of BOVILIS NASALGEN 3.
Duration of Immunity of the Bovine Respiratory Syncytial Virus Fraction
Results of this study demonstrate the duration of immunity of the BRSV fraction of BOVILS NASALGEN 3.
Duration of Immunity of the Infectious Bovine Rhinotracheitis Virus Fraction
Results of this study demonstrate the duration of immunity of the IBR fraction of BOVILIS® NASALGEN 3®.
Efficacy of the Bovine Parainfluenza 3 Virus Fraction
Results of this study demonstrate protective efficacy of the PI3 fraction of BOVILIS NASALGEN 3.
Efficacy of the Bovine Respiratory Syncytial Virus Fraction
Results of this study demonstrate the protective efficacy for the BRSV fraction of BOVILIS NASALGEN 3.
Efficacy of the Infectious Bovine Rhinotracheitis Virus Fraction
Results of this study demonstrate protective efficacy for the IBR fraction of BOVILIS NASALGEN 3.
No items to show.
For more cattle-friendly options, see the rest of the Merck Animal Health vaccine lineup.
1 Grissett GP, et al. Effect of Ambient Temperature on Viral Replication and Serum Antibody Titers Following Administration of a Commercial Intranasal Modified-Live Infectious Bovine Rhinotracheitis-Parainfluenza-3 Virus Vaccine to Beef Cattle Housed in High- and Moderate-Ambient Temperature Environments. Am J Vet Res. 2014;75(12):1076-1082.